CA Stock MarketDetailed Quotes
MDNA Medicenna Therapeutics Corp
- 1.790
- +0.070+4.07%
15min DelayMarket Closed Dec 17 16:00 ET
139.90MMarket Cap-4.71P/E (TTM)
1.800High1.680Low49.02KVolume1.720Open1.720Pre Close84.90KTurnover2.98052wk High0.10%Turnover Ratio78.16MShares0.38552wk Low-0.38EPS TTM91.23MFloat Cap7.250Historical HighLossP/E (Static)50.97MShs Float0.215Historical Low-0.37EPS LYR6.98%Amplitude--Dividend TTM6.96P/B1Lot Size--Div YieldTTM
About Medicenna Therapeutics Corp Company
Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL13 Superkines and Empowered Superkines for the treatment of cancer and other diseases. Its pipeline candidates include MDNA55 for recurrent glioblastoma multiforme (rGBM), MDNA11 for Cancer immunotherapies, MDNA209 for Autoimmune Diseases, MDNA413 for Cancer immunotherapies, and MDNA132 for Solid Tumors, BiSKITs represents the novel platform comprised of Bifunctional SuperKine ImmunoTherapies.
Company Profile
SymbolMDNA
Company NameMedicenna Therapeutics Corp
Founded2015
MarketTSE
Employees19
Fiscal Year Ends03-31
Address2 Bloor Street W. 7th Floor
CityToronto
CountryCAN
Zip CodeM4W 3E2
Websitehttps://www.medicenna.com
Company Executives
- Name
- Position
- Salary
- Dr. Fahar Merchant,PhD
- President, Chief Executive Officer and Chairman of the Board
- 877.19K
- David Hyman
- Chief Financial Officer
- --
- Rosemina Merchant
- Chief Development Officer
- 613.71K
- Dr. John Geltosky, PhD
- Independent Director
- 117.45K
- Dr. John H. Sampson, M.B.A.,M.D.,PhD
- Independent Director
- 111.83K
- Karen A. Dawes, M.A.
- Independent Director
- 123.70K
- Karim Lalji
- Independent Director
- --
- Albert Beraldo, C.A.,C.P.A.
- Lead Independent Director
- 142.95K
Heat List
CA
Overall
Symbol
Price
% Chg
No Data